2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,Heart Rhythm Society,

Andrea M. Russo, Raymond F. Stainback, Steven R. Bailey, Andrew E. Epstein, Paul A. Heidenreich, Mariell Jessup, Suraj Kapa, Mark S. Kremers, Bruce D. Lindsay, Lynne Warner Stevenson

Research output: Contribution to journalReview article

103 Citations (Scopus)

Abstract

The American College of Cardiology Foundation in colla e38 boration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverter e39 defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber lCD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of snidies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45% of the indications were rated as Appropriate, 33% were rated May Be Appropriate and 22% were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implanta tion. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appro priate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriate e45 ness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.

Original languageEnglish (US)
JournalHeart Rhythm
Volume10
Issue number4
DOIs
StatePublished - Apr 1 2013
Externally publishedYes

Fingerprint

Cardiac Resynchronization Therapy
Implantable Defibrillators
Advisory Committees
Equipment and Supplies
Comorbidity
Clinical Trials
Primary Prevention
Secondary Prevention
Life Expectancy
Practice Guidelines
Cognition
Decision Making
Delivery of Health Care
Physicians
inproquone
Therapeutics

Keywords

  • ACCF appropriate use criteria
  • CRT
  • electrophysiology
  • heart failure
  • ICD
  • implantable defibrillator
  • sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy : A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,Heart Rhythm Society, / Russo, Andrea M.; Stainback, Raymond F.; Bailey, Steven R.; Epstein, Andrew E.; Heidenreich, Paul A.; Jessup, Mariell; Kapa, Suraj; Kremers, Mark S.; Lindsay, Bruce D.; Stevenson, Lynne Warner.

In: Heart Rhythm, Vol. 10, No. 4, 01.04.2013.

Research output: Contribution to journalReview article

Russo, Andrea M. ; Stainback, Raymond F. ; Bailey, Steven R. ; Epstein, Andrew E. ; Heidenreich, Paul A. ; Jessup, Mariell ; Kapa, Suraj ; Kremers, Mark S. ; Lindsay, Bruce D. ; Stevenson, Lynne Warner. / 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy : A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,Heart Rhythm Society,. In: Heart Rhythm. 2013 ; Vol. 10, No. 4.
@article{bb53f85178fe4d5eb647ebe73026b8e4,
title = "2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,Heart Rhythm Society,",
abstract = "The American College of Cardiology Foundation in colla e38 boration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverter e39 defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber lCD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of snidies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45{\%} of the indications were rated as Appropriate, 33{\%} were rated May Be Appropriate and 22{\%} were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implanta tion. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appro priate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriate e45 ness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.",
keywords = "ACCF appropriate use criteria, CRT, electrophysiology, heart failure, ICD, implantable defibrillator, sudden death",
author = "Russo, {Andrea M.} and Stainback, {Raymond F.} and Bailey, {Steven R.} and Epstein, {Andrew E.} and Heidenreich, {Paul A.} and Mariell Jessup and Suraj Kapa and Kremers, {Mark S.} and Lindsay, {Bruce D.} and Stevenson, {Lynne Warner}",
year = "2013",
month = "4",
day = "1",
doi = "10.1016/j.hrthm.2013.01.008",
language = "English (US)",
volume = "10",
journal = "Heart Rhythm",
issn = "1547-5271",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - 2013 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy

T2 - A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force,Heart Rhythm Society,

AU - Russo, Andrea M.

AU - Stainback, Raymond F.

AU - Bailey, Steven R.

AU - Epstein, Andrew E.

AU - Heidenreich, Paul A.

AU - Jessup, Mariell

AU - Kapa, Suraj

AU - Kremers, Mark S.

AU - Lindsay, Bruce D.

AU - Stevenson, Lynne Warner

PY - 2013/4/1

Y1 - 2013/4/1

N2 - The American College of Cardiology Foundation in colla e38 boration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverter e39 defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber lCD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of snidies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45% of the indications were rated as Appropriate, 33% were rated May Be Appropriate and 22% were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implanta tion. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appro priate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriate e45 ness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.

AB - The American College of Cardiology Foundation in colla e38 boration with the Heart Rhythm Society and key specialty and subspecialty societies conducted a review of common clinical scenarios where implantable cardioverter e39 defibrillators (ICDs) and cardiac resynchronization therapy (CRT) are frequently considered. The clinical scenarios covered in this document address secondary prevention, primary prevention, comorbidities, generator replacement at elective replacement indicator, dual-chamber lCD, and CRT. The indications (clinical scenarios) were derived from common applications or anticipated uses, as well as from current clinical practice guidelines and results of snidies examining device implantation. The 369 indications in this document were developed by a multidisciplinary writing group and scored by a separate independent technical panel on a scale of 1 to 9 to designate care that is Appropriate (median 7 to 9), May Be Appropriate (median 4 to 6), and Rarely Appropriate (median 1 to 3). The final ratings reflect the median score of the 17 technical panel members: 45% of the indications were rated as Appropriate, 33% were rated May Be Appropriate and 22% were rated Rarely Appropriate. In general, Appropriate designations were assigned to scenarios for which clinical trial evidence and/or clinical experience was available that supported device implanta tion. By contrast, scenarios for which clinical trial evidence was limited or device implantation seemed reasonable for extenuating reasons were categorized as May Be Appro priate. Scenarios for which there were data showing harm, or no data were available, and medical judgment deemed device therapy ill-advised were categorized as Rarely Appropriate. For example, comorbidities including life expectancy and cognitive function impacted appropriate e45 ness ratings. The Appropriate Use Criteria for ICD/CRT have the potential to enhance physician decision making, healthcare delivery, and reimbursement policy. Furthermore, recognition of clinical scenarios rated as May Be Appropriate facilitates the identification of areas that would benefit from future research.

KW - ACCF appropriate use criteria

KW - CRT

KW - electrophysiology

KW - heart failure

KW - ICD

KW - implantable defibrillator

KW - sudden death

UR - http://www.scopus.com/inward/record.url?scp=84875925646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875925646&partnerID=8YFLogxK

U2 - 10.1016/j.hrthm.2013.01.008

DO - 10.1016/j.hrthm.2013.01.008

M3 - Review article

VL - 10

JO - Heart Rhythm

JF - Heart Rhythm

SN - 1547-5271

IS - 4

ER -